A549 cells infected with IAV Analysis Results (GEO series: GSE147507)
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr17_+_68165657 Show fit | 0.59 |
ENST00000243457.3
|
potassium inwardly-rectifying channel, subfamily J, member 2 |
|
chr15_-_78526942 Show fit | 0.49 |
ENST00000258873.4
|
acyl-CoA synthetase bubblegum family member 1 |
|
chr6_+_144471643 Show fit | 0.45 |
ENST00000367568.4
|
syntaxin 11 |
|
chr18_-_51751132 Show fit | 0.42 |
ENST00000256429.3
|
methyl-CpG binding domain protein 2 |
|
chr1_+_112162381 Show fit | 0.33 |
ENST00000433097.1
ENST00000369709.3 ENST00000436150.2 |
RAP1A, member of RAS oncogene family |
|
chr6_-_108395907 Show fit | 0.31 |
ENST00000193322.3
|
osteopetrosis associated transmembrane protein 1 |
|
chr8_-_103668114 Show fit | 0.30 |
ENST00000285407.6
|
Kruppel-like factor 10 |
|
chr3_-_87040233 Show fit | 0.29 |
ENST00000398399.2
|
vestigial like 3 (Drosophila) |
|
chr1_-_85156216 Show fit | 0.29 |
ENST00000342203.3
ENST00000370612.4 |
synovial sarcoma, X breakpoint 2 interacting protein |
|
chr12_-_76953284 Show fit | 0.27 |
ENST00000547544.1
ENST00000393249.2 |
oxysterol binding protein-like 8 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.6 | GO:0090076 | relaxation of skeletal muscle(GO:0090076) |
0.0 | 0.6 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
0.0 | 0.6 | GO:0035338 | long-chain fatty-acyl-CoA biosynthetic process(GO:0035338) |
0.0 | 0.5 | GO:0099500 | synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
0.1 | 0.4 | GO:1903347 | negative regulation of bicellular tight junction assembly(GO:1903347) |
0.1 | 0.3 | GO:2000301 | response to antineoplastic agent(GO:0097327) negative regulation of synaptic vesicle exocytosis(GO:2000301) |
0.0 | 0.3 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.0 | 0.3 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.0 | 0.3 | GO:0090204 | protein localization to nuclear pore(GO:0090204) |
0.0 | 0.3 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.3 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.0 | 0.3 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.1 | 0.2 | GO:0031213 | RSF complex(GO:0031213) |
0.0 | 0.2 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.0 | 0.2 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
0.0 | 0.2 | GO:0098837 | postsynaptic recycling endosome(GO:0098837) |
0.0 | 0.2 | GO:0033503 | HULC complex(GO:0033503) |
0.0 | 0.2 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
0.0 | 0.2 | GO:0033391 | chromatoid body(GO:0033391) |
0.0 | 0.2 | GO:0031209 | SCAR complex(GO:0031209) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 0.6 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
0.0 | 0.5 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.0 | 0.4 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.1 | 0.3 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
0.0 | 0.3 | GO:0050733 | RS domain binding(GO:0050733) |
0.0 | 0.3 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.0 | 0.3 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.0 | 0.2 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.0 | 0.2 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.0 | 0.2 | GO:1904455 | ubiquitin-specific protease activity involved in negative regulation of ERAD pathway(GO:1904455) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 0.5 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.0 | 0.4 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.0 | 0.2 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 0.5 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.0 | 0.4 | REACTOME G PROTEIN BETA GAMMA SIGNALLING | Genes involved in G-protein beta:gamma signalling |
0.0 | 0.4 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.0 | 0.4 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.0 | 0.3 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.0 | 0.3 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.0 | 0.2 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.0 | 0.1 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |